Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2003
05/01/2003WO2003036261A2 Drug development by rapid neuroimaging of neural cells
05/01/2003WO2003036259A2 Assay for phospholipid transfer protein (pltp) activity
05/01/2003WO2003036258A2 System and method for determining radius of gyration, molecular weight, and intrinsic viscosity of a polymeric distribution using gel permeation chromatography and light-scattering detection
05/01/2003WO2003036257A2 Immobilizing biological molecules
05/01/2003WO2003036225A1 Method for biomolecular sensing and system thereof
05/01/2003WO2003035908A1 Method of detecting hereditary factors for hypertension
05/01/2003WO2003035904A2 Methods and compositions to evaluate antibody treatment response
05/01/2003WO2003035901A1 Assay method for measurement of net cholesterol flux
05/01/2003WO2003035899A1 Method of separating blood cells from microorganism in blood and mehtod of detecting microorganism in blood
05/01/2003WO2003035898A1 Method of screening drug acting on cell wall
05/01/2003WO2003035897A2 Enzyme substrates for detecting beta-d-ribofuranosidase activity
05/01/2003WO2003035896A2 Chromogenic enzyme substrates and method for detecting beta-d-ribofuranosidase activity
05/01/2003WO2003035895A2 Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
05/01/2003WO2003035894A2 Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
05/01/2003WO2003035872A1 Human and mammalian stem cell-derived neuronal survival polypeptides
05/01/2003WO2003035871A1 Promoter dna
05/01/2003WO2003035866A1 Method of evaluating and identifying biologically functional molecule using marker gene
05/01/2003WO2003035864A1 Method of detecting target nucleic acid and nucleic acid probe
05/01/2003WO2003035858A2 Bacterial polypeptides involved in nucleic acid processing
05/01/2003WO2003035854A1 Skeletal cell model to screen anti-diabetic compounds
05/01/2003WO2003035848A1 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer
05/01/2003WO2003035841A2 Methods and systems for dynamic gene expression profiling
05/01/2003WO2003035840A2 69583 and 85924, novel human protein kinase family members and uses therefor
05/01/2003WO2003035839A2 Target specific screening andits use for identifying target binders
05/01/2003WO2003035838A2 Stem cells that transform to beating cardiomyocytes
05/01/2003WO2003035837A2 Novel compositions and methods for cancer
05/01/2003WO2003035833A2 Modifier of the p53 pathway and methods of use
05/01/2003WO2003035832A2 Ctsls as modifiers of the p53 and apaf-1 pathways and methods of use
05/01/2003WO2003035831A2 Lrrcaps as modifiers of the p53 pathway and methods of use
05/01/2003WO2003035829A2 Nanoparticles having oligonucleotides attached thereto and uses therefor
05/01/2003WO2003035825A2 Photovoltaic device to accelerate the interaction among biomolecules
05/01/2003WO2003035824A1 Interactive transparent individual cells biochip processor
05/01/2003WO2003035694A2 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
05/01/2003WO2003035693A2 Crystals of cytochrome p450 2c9, structures thereof and their use
05/01/2003WO2003035687A1 Nogo receptor homologues and their use
05/01/2003WO2003035681A2 Mycobacterial genes down-regulated during latency
05/01/2003WO2003035679A2 Molecules
05/01/2003WO2003035678A2 Sperm factor sequences
05/01/2003WO2003035671A2 Methods for detecting genetic haplotypes by interaction with probes
05/01/2003WO2003035670A2 Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis
05/01/2003WO2003035665A1 Modified l-nucleic acid
05/01/2003WO2003035477A1 Specimen vial sealing apparatus and method
05/01/2003WO2003035239A2 Resin dispensing device
05/01/2003WO2003035233A1 Separating device, analysis system, separation method and method for manufacture of separating device
05/01/2003WO2003035229A2 Integrated fluidic device for sample preparation and assay
05/01/2003WO2003035208A1 Method for preparation of microarrays for screening of crystal growth conditions
05/01/2003WO2003035050A2 Use of tyrosine kinase inhibitors for promoting hair growth
05/01/2003WO2003035049A2 Use of potent, selective and non-toxic c-kit inhibitors for treating bacterial infections
05/01/2003WO2003035006A2 Amyloid ss is a ligand for fpr class receptors
05/01/2003WO2003034996A2 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment
05/01/2003WO2003034984A2 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003WO2003034981A2 Prevention of recurrent viral disease
05/01/2003WO2003034903A2 Psma antibodies and protein multimers
05/01/2003WO2003034819A2 Nox software sensor
05/01/2003WO2003034803A2 Methods for determining toxicity reversing agents
05/01/2003WO2003021231A3 Method and apparatus for normalization and deconvolution of assay data
05/01/2003WO2003020985B1 Detection of genetic sequences using a bipartite probe
05/01/2003WO2003019176A3 Method and apparatus for determination of water and for normal phase liquid chromatography
05/01/2003WO2003013578A8 Omoxin agonists and antagonists for use in the treatment of metabolic disorders
05/01/2003WO2003012816A3 Mobile miniature x-ray source
05/01/2003WO2003008622A3 Exponential nucleic acid amplification using nicking endonucleases
05/01/2003WO2003006684A3 Device and method for detecting photosynthesis inhibition
05/01/2003WO2003006675A3 Methods and devices based upon a novel form of nucleic acid duplex on a surface
05/01/2003WO2003005028A8 Method for selecting bioactive agents by luminescence coupling and living cell system therefor
05/01/2003WO2003003162A3 Evaluating neuropsychiatric diseases using a specimen-linked database
05/01/2003WO2003001191A3 Monitoring of gas sensors
05/01/2003WO2002101395A3 Rapid pharmaceutical component screening devices and methods
05/01/2003WO2002101339A3 Imaging and analyzing parameters of small moving objects such as cells
05/01/2003WO2002101022A3 Method for rapid amplification of dna
05/01/2003WO2002100336A3 Tissue-specific endothelial membrane proteins
05/01/2003WO2002099432A3 Quinacridone labelling reagents for fluorescence detection of biological materials
05/01/2003WO2002099055A3 Cips as modifiers of the p53 pathway and method of use
05/01/2003WO2002099046A3 Spo11 as modifier of the p53 pathway and methods of use
05/01/2003WO2002098897A3 Modified antibodies to prostate-specific membrane antigen and uses thereof
05/01/2003WO2002098444A3 Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis
05/01/2003WO2002098347A3 Methods and compositions that affect melanogenesis (pfi-016cip/pct)
05/01/2003WO2002098287A3 A high throughput biological heart rate monitor that is molecularly determined
05/01/2003WO2002097392A3 Sample concentration maldi plates for maldi mass spectrometry
05/01/2003WO2002093129A3 Methods for analyzing interactions between proteins in live and intact cells
05/01/2003WO2002090498A3 A high throughput assay for identification of gene expression modifiers
05/01/2003WO2002089340A3 A system and method for managing procedures in a blood component collection facility
05/01/2003WO2002088709A3 Method for monitoring and validating stress induction of disease state
05/01/2003WO2002083712A3 Transporters and ion channels
05/01/2003WO2002081513A3 Disease-associated protein
05/01/2003WO2002077641A3 Reference electrode
05/01/2003WO2002077231A3 Nucleic acid-associated proteins
05/01/2003WO2002075280A3 Examination device and method for examination of chemical and/or biological samples
05/01/2003WO2002072887A3 Immobilisation of ligands using saccharides
05/01/2003WO2002066983A3 Bioassay device for detecting molecular events
05/01/2003WO2002063007A3 TIMM8b-RELATED PROTEIN
05/01/2003WO2002059356A3 Method for screening compounds for activity in treating an osteoclast related bone disease
05/01/2003WO2002057753A3 Rapid test for biological substances using ftir
05/01/2003WO2002057496A9 Gene expression profiling of endothelium in alzheimer's disease
05/01/2003WO2002055995A3 Method and system for modeling cellular metabolism
05/01/2003WO2002055988A3 Novel methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators
05/01/2003WO2002053017A3 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
05/01/2003WO2002052245A3 Rapid particle detection
05/01/2003WO2002050534A9 Device for measuring blood coagulation and method thereof
05/01/2003WO2002048717A3 Acid-labile isotope-coded extractant (alice) in mass spectrometric analysis
05/01/2003WO2002046476A3 Genotyping using partially-complementary probes
1 ... 2599 2600 2601 2602 2603 2604 2605 2606 2607 2608 2609 2610 2611 2612 2613 2614 2615 2616 2617 2618 2619 ... 3937